EuRRECa Project Group Meeting Webinar

Following the necessary cancellation of the face-to-face meeting of the EuRRECa Project Group in Verbania, we are pleased to inform you that a Webinar is being arranged as an alternative on the same date.Monday 9 March 2020

The meeting will begin at 10:50 and finish at 13:10 (CET).

The PGB meeting which will be held after the Project Group meeting.

Endo-ERN GA2020 Webinar

Following the necessary cancellation of the face-to-face meeting of the Endo-ERN General Assembly in Verbania, we are pleased to inform that a Webinar is being arranged as a concise alternative for the F2F meeting on the first of the two settled dates: Tuesday 10 march 2020.

We are currently working on the (shortened) definitive programme, which will be announced on Tuesday 3 March.
The meeting will consist of two parts: morning session: 11:00-13.00, and afternoon session: 14.00-15.30/16.00 (CET).

The Steering Committee & Advisory board meeting will be held prior to the General Assembly (9.30-10.30 CET).

LUMC is actively involved in the international approach to rare diseases

How can we help patients with a rare disease in the best possible way? On Tuesday, February 18, the European strategy on rare diseases was discussed during the Rare Disease Day Policy Event with members of the European Parliament in Brussels. The Leiden University Medical Center (LUMC) was represented by. LUMC professor prof. Alberto Pereira as invited speaker, and as coordinator of the European reference network on rare endocrine conditions (Endo-ERN) sharing his experiences and vision for the future.

 

A person is considered having a rare disease if his or her condition affects less than 1 in 2,000 people, which means that about 30 million people livewith a rare condition in the European Union. It is estimated that around 6,000 rare diseases occur in Europe. Because these diseases require specialized and often complex treatment, patients often have difficulty acquiring  the correct diagnosis and appropriate treatment and care.

To provide patients access to the best care, it is important that health care providers (HCPs) from all over Europe actively exchange the required knowledge with each other. The ERN Hospital Managers network plays an important role in facilitating these European Reference Networks (ERNs). By bringing together specialists from across Europe, patients can be helped much faster and better in the future. Willy Spaan, chairman of the Board of Directors of LUMC, is the present chairman of this active network of European directors of academic medical centers and hospitals.

 

Rare Disease Day Policy Event

At the Rare Disease Day Policy Event stakeholders discuss what is needed in Europe to better respond to the needs of patients with a rare disease. Various leading healthcare professionals, policy makers and patients discussed the access to (orphan) medicines, holistic and patient-oriented care, research into patient-relevant outcome measures, and the effectiveness and added value of cross-border healthcare.

The LUMC strategically focuses on value-based healthcare, with the patient’s perspective playing a major role in shaping care. Several care pathways for patients with a many rare conditions have already been developed.

At LUMC, doctors and researchers are already dealing with 125 different rare diseases in 40 centers of expertise. The knowledge and experiences are discussed in Brussels. Among other things, Pereira explained the importance of joint research funding for ERNs, a coordinated access to data and services, capacity building, and the need fora rapid translation of research and therapy development.

 

International collaboration 

To further improve care for patients with a rare disease, health care professionals, researchers and patient representatives at LUMC have been exchanging specialist knowledge with other colleagues in the field through participation in 8 ERNs since 2017.. The LUMC is the coordinating center in Europe of the ERN on Rare Endocrine Conditions (Endo-ERN). By using novel ICT technology developed by the European Commission, the Clinical Patient Management System (CPMS), virtual consultation by a panel of Multidisciplinary experts enables patients with rare diseases from other European countries to obtain the required expertise without having to travel to the LUMC.

The LUMC is also a member of the International Rare Diseases Research Consortium (IRDiRC). This consortium is working on one clear mission: to provide all people with rare diseases with a precise diagnosis, the best care and therapy within one year after medical assistance.

This entry was posted in General.

Endo-ERN webinar: Prophylactic thyroidectomy in Children with MEN2

On Friday February 21st at 15:30 – 16:30 CET an Endo-ERN webinar about “Prophylactic thyroidectomy in Children with MEN2” is organised.

Multiple Endocrine Neoplasia type 2 is an autosomal dominant inherited tumour syndrome which occurs in 1:200000 live birth and have an estimated prevalence of 1:30 000 to 1:40 000 individuals.

It is caused by mutation of RET protooncogene located on 10q11.2 which encodes a transmembrane receptor tyrosine kinase. RET mutations are also responsible for Hirschprung disease, urogenital abnormalities and other pathologies.All  MEN2 patients develop medullary thyroid cancer, half of them pheochromocytoma and 10-20% Primary Hyperparathyroidism. RET mutations have been classified according to their aggressiveness and age at which MTC develop.

Prophylactic thyroidectomy in children diagnosed with MEN2 is a recommended treatment and in this webinar Prof. Tom Kurzawinski will talk about timing of surgery as well as its outcomes.

Webinar summary

WebinarProphylactic thyroidectomy in Children with MEN2
DateFebruary 21st, 2020
SpeakerTom Kurzawinski
RegistrationRegistration is closed
View
MTG

Rare Disease Day in Dimed – Research Project

29 February 2020 will be the thirteenth international Rare Disease Day coordinated by EURORDIS. On and around this day hundreds of (patient) organisations from countries and regions all over the world will hold awareness-raising activities.

In Padova, Italy, a meeting regarding research about rare diseases is organized.

The programme can be found here. MTG 3 Adult chair Pietro Maffei is part of the Scientific Committee.

Event summary

EventRare Disease Day in Dimed – Research Project
DateFebruary 28th - February 29th, 2020
LocationPadova, Italy
WebsiteVisit event website

EJPRD – ERN internal training and support program calls

EJP-RD has opened funding calls for training programs based on two main components: research mobility fellowship and research training workshops.

The aim of these programs is to fill the gap in the available education on rare diseases research by creating and implementing a comprehensive and cohesive program of education and empowerment for different target groups or stakeholders such as researches and young clinicians.

Submission for the fellowship is possible until 16th of March 2020. For the research training workshops, the deadline for submission is 2nd of March.

For more information, visit the website.

This entry was posted in General.

e-ECE 2020

e-ECE 2020 is a fully digital congress, with the latest innovations in endocrine research and patient care. e-ECE will be held from 5-9 September 2020. The online congress will exist out of high quality lectures, symposia, Meet the Expert sessions, New Scientific Approaches and much more.

The virtual exhibition, ECE Hub sessions and satellite symposia will enable you to stay up to date with industry. There will also be plenty of opportunities to meet online, extend your network and spark discussions.

 

Event summary

Evente-ECE 2020
DateSeptember 5th - September 9th, 2020
OrganisationThe European Society of Endocrinology
WebsiteVisit event website
RegistrationRegistration is closed

 

 

Bone Curriculum Symposium

This year the Bone Curriculum Symposium will take place at Het Pand in Ghent, Belgium on 12 & 13 March 2020.

The bone curriculum serves as a lecture cycle on bone which is covered within three consecutive yearly symposia. The scope of the bone curriculum is to provide high quality continuous education for clinicians of all specialities interested in, seeing or treating patients with osteoporosis and / or bone diseases and is also a structured educational programme for trainees in rheumatology and other specialities looking at bone and calcium – phosphate metabolism disorders.

Event summary

EventBone Curriculum Symposium
DateMarch 12th - March 13th, 2020
LocationGhent, Belgium
OrganisationKBVR/SRBR Osteoporosis and Fracture Prevention Group
WebsiteVisit event website
RegistrationRegistration is closed

Endo-ERN webinar: Turner Syndrome Guideline & the patient perspective

On Thursday February 13th at 15:00 – 16:00 CET an Endo-ERN webinar about “Turner Syndrome Guideline & the patient perspective” is organised.

The webinar will be held by Prof. Claus Gravholt, MD, PhD, Aarhus University Hospital Denmark and Arlene Smyth, mother of a patient, Executive Officer of the Turner Syndrome Support Society and Endo-ERN patient representative.

Claus Gravholt will give a short description of the new international guideline concerning health and general follow-up of adult women with Turner syndrome. He will focus on the medical health issues, as well as the neurocognitive challenges that many women with TS face during adulthood and about the need for centralized care in all countries, as well as the interdisciplinarity which is needed. Furthermore, Arlene Smyth will be sharing the patient perspective side. Continue reading